Anthracycline-free neoadjuvant therapy with nab-paclitaxel and carboplatin in nonluminal breast cancer: a single-arm phase II trial

被引：0
|
作者：
Liu, Deyue
Zhu, Li
Wu, Jiayi
Wang, Wei
Ding, Shuning
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO5-18-09
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO5-18-09
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Neoadjuvant camrelizumab plus nab-paclitaxel and epirubicin in early triple-negative breast cancer: a single-arm phase II trial
    Wang, Chengzheng
    Liu, Zhenzhen
    Chen, Xiuchun
    Qiao, Jianghua
    Lu, Zhenduo
    Li, Lianfang
    Sun, Xianfu
    Zhang, Chongjian
    Yue, Xiayu
    Xia, Qingxin
    Zhang, He
    Yan, Min
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [2] Neoadjuvant camrelizumab plus nab-paclitaxel and epirubicin in early triple-negative breast cancer: a single-arm phase II trial
    Chengzheng Wang
    Zhenzhen Liu
    Xiuchun Chen
    Jianghua Qiao
    Zhenduo Lu
    Lianfang Li
    Xianfu Sun
    Chongjian Zhang
    Xiayu Yue
    Qingxin Xia
    He Zhang
    Min Yan
    Nature Communications, 14 (1)
  • [3] Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple-Negative Breast Cancer
    Yuan, Yuan
    Lee, Jin Sun
    Yost, Susan E.
    Li, Sierra Min
    Frankel, Paul H.
    Ruel, Christopher
    Schmolze, Daniel
    Robinson, Kim
    Tang, Aileen
    Martinez, Norma
    Stewart, Daphne
    Waisman, James
    Kruper, Laura
    Jones, Veronica
    Menicucci, Andrea
    Uygun, Sahra
    Yoder, Erin
    van der Baan, Bastiaan
    Yim, John H.
    Yeon, Christina
    Somlo, George
    Mortimer, Joanne
    ONCOLOGIST, 2021, 26 (03): : E382 - E393
  • [4] Neoadjuvant anthracycline followed by toripalimab combined with nab-paclitaxel in patients with early triple-negative breast cancer (NeoTENNIS): a single-arm, phase II study
    He, Min
    Hao, Shuang
    Ma, LinXiaoxi
    Xiu, BingQiu
    Yang, BenLong
    Wang, ZeHao
    Xue, JingYan
    Chi, YaYun
    Xiong, Min
    Chen, Jiajian
    Huang, XiaoYan
    Liu, XiYu
    Wu, SongYang
    Xiao, Qin
    Huang, Yan
    Shui, RuoHong
    Cao, AYong
    Li, JunJie
    Di, GenHong
    Yang, WenTao
    Hu, Xin
    Liu, GuangYu
    Yu, KeDa
    Jiang, YiZhou
    Wang, ZhongHua
    Shao, ZhiMing
    Wu, Jiong
    ECLINICALMEDICINE, 2024, 74
  • [5] A phase II trial of neoadjuvant apatinib combined with nab-paclitaxel and carboplatin in triple-negative breast cancer
    Zeng, Tianyu
    Wang, Jue
    Li, Wei
    Sun, Chunxiao
    Yang, Fan
    Liang, Yan
    Fu, Ziyi
    Zha, Xiaoming
    Yin, Yongmei
    ANNALS OF ONCOLOGY, 2022, 33 : S492 - S492
  • [6] Phase II trial of neoadjuvant carboplatin and nab-paclitaxel in patients with locally advanced triple negative breast cancer
    Yuan, Y.
    Frankel, P.
    Li, M.
    Kruper, L.
    Jones, V.
    Treece, T.
    Waisman, J.
    Yim, J.
    Tumyan, L.
    Schmolze, D.
    Hurria, A.
    Yeon, C.
    Mortimer, J.
    Somlo, G.
    CANCER RESEARCH, 2019, 79 (04)
  • [7] Phase II trial of neoadjuvant chemotherapy with carboplatin and nab-paclitaxel in patients with triple negative locally advanced and inflammatory breast cancer
    Somlo, G.
    Chung, S.
    Frankel, P.
    Hurria, A.
    Koehler, S.
    Kruper, L.
    Mortimer, J. E.
    Paz, B.
    Robinson, K.
    Taylor, L.
    Vito, C.
    Waisman, J.
    Yeon, C.
    Yim, J.
    Yuan, Y.
    Tong, T.
    CANCER RESEARCH, 2016, 76
  • [8] Nab-paclitaxel maintenance therapy following carboplatin plus nab-paclitaxel combination therapy in chemotherapy naive patients with advanced non-small cell lung cancer: multicenter, open-label, single-arm phase II trial
    Nakao, Akira
    Uchino, Junji
    Igata, Fumiyasu
    On, Rintaro
    Ikeda, Takato
    Yatsugi, Hiroshi
    Hirano, Ryosuke
    Sasaki, Tomoya
    Tanimura, Keiko
    Imabayashi, Tatsuya
    Tamiya, Nobuyo
    Kaneko, Yoshiko
    Yamada, Tadaaki
    Nagata, Nobuhiko
    Watanabe, Kentaro
    Kishimoto, Junji
    Takayama, Koichi
    Fujita, Masaki
    INVESTIGATIONAL NEW DRUGS, 2018, 36 (05) : 903 - 910
  • [9] Nab-paclitaxel maintenance therapy following carboplatin + nab-paclitaxel combination therapy in chemotherapy naïve patients with advanced non-small cell lung cancer: multicenter, open-label, single-arm phase II trial
    Akira Nakao
    Junji Uchino
    Fumiyasu Igata
    Rintaro On
    Takato Ikeda
    Hiroshi Yatsugi
    Ryosuke Hirano
    Tomoya Sasaki
    Keiko Tanimura
    Tatsuya Imabayashi
    Nobuyo Tamiya
    Yoshiko Kaneko
    Tadaaki Yamada
    Nobuhiko Nagata
    Kentaro Watanabe
    Junji Kishimoto
    Koichi Takayama
    Masaki Fujita
    Investigational New Drugs, 2018, 36 : 903 - 910
  • [10] Phase II trial of weekly nab-paclitaxel and carboplatin treatment with or without trastuzumab as nonanthracycline neoadjuvant chemotherapy for locally advanced breast cancer
    Huang, Liang
    Chen, Sheng
    Yao, Ling
    Liu, Guangyu
    Wu, Jiong
    Shao, Zhiming
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2015, 10 : 1969 - 1975
12345